Journal
TRENDS IN IMMUNOLOGY
Volume 34, Issue 2, Pages 50-58Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2012.08.009
Keywords
invariant natural killer T cells; CD1d; glycolipids; inflammation; immunotherapy
Categories
Funding
- National Institutes of Health
- National Multiple Sclerosis Society
Ask authors/readers for more resources
Invariant natural killer T (iNKT) cells are a subset of innate-like lymphocytes that recognize glycolipid antigens bound by the major histocompatibility complex (MHC)-class-I-related protein CD1d. iNKT cells are activated early during a variety of infections and inflammatory diseases and contribute to the subsequent development of adaptive immune responses. Consequently, iNKT cells play a critical role in the development and resolution of inflammatory diseases and represent attractive targets for the development of immunotherapies. Recent studies have provided important insight into the mechanisms by which iNKT cells become activated in response to diverse inflammatory stimuli. These new findings should be instrumental to promote the immunomodulatory properties of iNKT cells for treatment of inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available